Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nickolay A. Kryuchkov"'
Autor:
Aleksandr V. Kudriavtsev, Anna V. Vakhrusheva, Nickolay A. Kryuchkov, Maria E. Frolova, Konstantin A. Blagodatskikh, Taras V. Ivanishin, Milana Djonovic, Ekaterina A. Romanovskaya-Romanko, Anton N. Kovalenko, Dmitry A. Lioznov, Tatiana G. Zubkova, Svetlana V. Teplykh, Rodion A. Oseshnyuk, Marina A. Stukova, Artur A. Isaev, Igor V. Krasilnikov
Publikováno v:
Vaccines, Vol 11, Iss 2, p 326 (2023)
COVID-19, being a life-threatening infection that evolves rapidly, remains a major public health concern calling for the development of vaccines with broad protection against different pathogenic strains and high immunogenicity. Aside from this, othe
Externí odkaz:
https://doaj.org/article/6fbf32a2521448a5b2cad584c69fbc01
Autor:
Anna V. Vakhrusheva, Aleksandr V. Kudriavtsev, Nickolay A. Kryuchkov, Roman V. Deev, Maria E. Frolova, Konstantin A. Blagodatskikh, Milana Djonovic, Andrey A. Nedorubov, Elena Odintsova, Aleksandr V. Ivanov, Ekaterina A. Romanovskaya-Romanko, Marina A. Stukova, Artur A. Isaev, Igor V. Krasilnikov
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1290 (2022)
Public health threat coming from a rapidly developing COVID-19 pandemic calls for developing safe and effective vaccines with innovative designs. This paper presents preclinical trial results of “Betuvax-CoV-2”, a vaccine developed as a subunit v
Externí odkaz:
https://doaj.org/article/851cfce278b44cd98b921243d6ba8a58
Publikováno v:
Current Medical Research and Opinion. 35:1003-1009
Currently, biotherapeutic medicines are the most effective options for the treatment of many severe and chronic diseases. For faster market entry of biotherapeutic products and their cost reduction, the principles of "biosimilarity" have been develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12585767a8d93ba17fbd3252985ef0bc
https://doi.org/10.1080/03007995.2018.1552041
https://doi.org/10.1080/03007995.2018.1552041